Regional Medicines Information and Pharmacovigilance Centre (RELIS Vest), Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, 5021, Bergen, Norway.
Department of Clinical Science, Faculty of Medicine and Dentistry, University of Bergen, 5021, Bergen, Norway.
Matern Child Health J. 2020 May;24(5):531-536. doi: 10.1007/s10995-020-02903-9.
Approximately 80% of pregnant women use medications. There is a need for evidence based medicines information that provide realistic risk estimates as pregnant and breastfeeding women tend to overestimate the risk of medications. The purpose of this paper is to describe the development and future perspectives of an innovative medicines information service aiming to increase empowerment among pregnant and breastfeeding women.
SafeMotherMedicine (SMM) (www.tryggmammamedisin.no) is a Norwegian medicines information service for pregnant and breastfeeding women. Established in 2011, the service was initially web-based only, in contrast to most teratology information services that at the time mainly operated using telephone and/or e-mail.
During the last eight years, SMM has provided close to 30,000 answers promoting appropriate medication use among pregnant and breastfeeding women. SMM launched a telephone-service in 2016, however, the annual number of questions received through the web-based service continues to increase.
The service seems to have fulfilled a previously unmet need of evidence-based, individually tailored information about medications to pregnant and breastfeeding women in Norway. SMM empowers the women to make informed decisions regarding medication use in pregnancy and breastfeeding, thus contributing to person-centred medicine. The web-based design of the service may represent the pregnant and breastfeeding women's preferred way of communication.
大约 80%的孕妇使用药物。需要提供基于证据的药物信息，提供现实的风险估计，因为孕妇和哺乳期妇女往往高估药物的风险。本文的目的是描述一种创新药物信息服务的发展和未来展望，旨在增强孕妇和哺乳期妇女的权能。
SafeMotherMedicine（SMM）（www.tryggmammamedisin.no）是一个为孕妇和哺乳期妇女提供的挪威药物信息服务。该服务成立于 2011 年，最初仅在网上运作，与当时主要通过电话和/或电子邮件运作的大多数致畸信息服务形成对比。
在过去的八年中，SMM 已经提供了近 30000 个答案，促进了孕妇和哺乳期妇女适当使用药物。SMM 于 2016 年推出了电话服务，但通过网络服务收到的年度问题数量继续增加。
该服务似乎满足了挪威孕妇和哺乳期妇女对基于证据、个性化的药物信息的未满足需求。SMM 使妇女能够就怀孕期间和哺乳期使用药物做出明智的决定，从而有助于实现以人为本的医学。该服务的网络设计可能代表了孕妇和哺乳期妇女首选的沟通方式。
